Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Chloroquine phosphate
Drug ID BADD_D00441
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D02125
MeSH ID C023676
PubChem ID 64927
TTD Drug ID D09EGZ
NDC Product Code 50090-4967; 64980-177; 68022-7057; 73377-214; 0115-2790; 68022-0264; 76385-142; 0115-7010; 64980-178; 62135-717; 57451-1116; 73377-028; 68022-0265; 23155-850; 63850-8080
UNII 6E17K3343P
Synonyms chloroquine diphosphate | chingamin phosphate | N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, phosphate (1:2) | delagil | khingamin phosphate | unspecified phosphate of chloroquine diphosphate | arechin | chloroquine phosphate | Resochin | chloroquine diphosphate, (+-)-isomer | chloroquine diphosphate, (-)-isomer | chloroquine bis(dihydrogenphosphate) dihydrate | chloroquine diphosphate, (+)-isomer
Chemical Information
Molecular Formula C18H32ClN3O8P2
CAS Registry Number 50-63-5
SMILES CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Agitation19.06.02.001; 17.02.05.012--
Agranulocytosis01.02.03.001--Not Available
Alopecia23.02.02.001--
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Anxiety19.06.02.002--
Aplastic anaemia01.03.03.002--Not Available
Cardiomyopathy02.04.01.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Corneal opacity06.06.03.005--Not Available
Deafness neurosensory17.04.07.001; 04.02.01.002--Not Available
Delirium19.13.02.001--
Depression19.15.01.001--
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Erythema multiforme10.01.03.015; 23.03.01.003--
Hair colour changes23.02.06.001--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hepatitis09.01.07.004--Not Available
Hypotension24.06.03.002--
Insomnia19.02.01.002; 17.15.03.002--
Muscle atrophy17.05.03.004; 15.05.03.003--Not Available
Muscular weakness17.05.03.005; 15.05.06.001--
Myopathy15.05.05.001--Not Available
Nausea07.01.07.001--
Nerve conduction studies abnormal13.07.03.002--Not Available
Neuromyopathy17.05.03.003; 15.05.03.010--Not Available
Neutropenia01.02.03.004--Not Available
Night blindness06.02.10.010; 14.12.03.001--
The 1th Page    1 2    Next   Last    Total 2 Pages